Downregulation of CRKL expression can inhibit tumorigenesis in colon cancer

Bin Lan1, Jian Zhang2, Jingxuan Shan3

  • 1Department of gastroenterology, the First Affiliated Hospital, Fujian Medical University, 20 Chazhong Rd, Fuzhou 350005, Fujian Province, China.

Insights

The CRKL protein promotes colon cancer malignancy by increasing cell proliferation, migration, and invasion. CRKL may serve as a diagnostic marker and therapeutic target for colon cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • The CRKL protein acts as a crucial "switch" factor in various oncogenic pathways, influencing multiple cancer types.
  • Limited information exists regarding the role of CRKL in gastrointestinal cancers, particularly colon cancer.

Purpose of the Study:

  • To investigate the involvement and function of CRKL in colon cancer.
  • To evaluate CRKL as a potential diagnostic and prognostic marker, as well as a therapeutic target for colon cancer.

Main Methods:

  • Immunohistochemistry was used to analyze CRKL expression in colon tumor tissues compared to normal tissues.
  • CRKL was suppressed in colon cancer cells to assess its impact on cell proliferation, migration, invasion, and apoptosis.
  • Xenograft models in nude mice were employed to study the effect of CRKL on tumorigenesis.

Main Results:

  • CRKL expression was significantly elevated in colon tumor tissues compared to normal tissues.
  • Higher CRKL levels correlated with poorer tumor differentiation.
  • Suppression of CRKL inhibited colon cancer cell proliferation, migration, and invasion, while inducing apoptosis.
  • CRKL was found to promote tumorigenesis in vivo.

Conclusions:

  • CRKL plays a significant role in regulating the malignancy of colon cancer.
  • CRKL demonstrates potential as a diagnostic and prognostic biomarker for colon cancer.
  • CRKL represents a promising therapeutic target for colon cancer treatment.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K